Dexcom Announces Upcoming Conference Presentation

Audio By Carbonatix

SAN DIEGO--(BUSINESS WIRE)--Feb 25, 2026--

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 47 th Annual Raymond James Institutional Investors Conference on Monday, March 2, 2026.

The live presentation is scheduled to begin at approximately 1:05 PM EST and will be concurrently webcast.

Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

About DexCom, Inc.

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

Category: IR

View source version on businesswire.com:https://www.businesswire.com/news/home/20260225371506/en/

CONTACT: DexCom, Inc.

Sean Christensen

Vice President – Finance and Investor Relations

[email protected]

(858) 200-0200

KEYWORD: CALIFORNIA FLORIDA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY DIABETES MEDICAL DEVICES HEALTH HEALTH TECHNOLOGY

SOURCE: DexCom, Inc.

Copyright Business Wire 2026.

PUB: 02/25/2026 08:30 AM/DISC: 02/25/2026 08:32 AM

http://www.businesswire.com/news/home/20260225371506/en